This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Analysis of genetic ablation of mutant Kras versus its inhibition in lung adenocarcinoma
Information
Date: 14/07/2022
Time 11:00
Venue: CNIO Auditorium and online
Conference Speaker Marina Salmón
Institution Experimental Oncology Group, Molecular Oncology Programme
Supervised by Mariano Barbacid and Matthias Drosten, Experimental Oncology Group, Molecular Oncology Programme
Free admission until full capacity is reached